# Corning Incorporated  Share Price Target ‘$38.73’, now .9% Upside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-share-price-target-38.73-now.9-upside-potential/4121163679
- Published: 2024-07-04T11:49:19+01:00
- Author: Charlotte Edwards

**Corning Incorporated** with ticker code (GLW) now have 13 market analysts covering
the stock. The analyst consensus now points to a rating of ‘buy’. The target price
High/Low ranges between $45.00 and $29.00 calculating the mean target share price
we have $38.73. (at the time of writing). Given that the stocks previous close was
at $38.39 this is indicating there is a potential upside of .9%. Also worth taking
note is the 50 day moving average now sits at $36.12 and the 200 moving average 
now moves to $31.84. The total market capitalization for the company now stands 
at 32.91B. The current share price for the company is: $38.42 USD

 The potential market cap would be $33,202,778,655 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 53.36, revenue per share of $14.57
and a 2.85% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on: